Retinoic acid-inducible gene I (RIG-I)-like receptors are cytosolic pattern recognition receptors (PRRs) that detect non-self-RNA and activate downstream interferon (IFN) signaling. One of the RIG-I-like receptors, laboratory of genetics and physiology 2 (LGP2), was originally thought to be a negative feedback regulator in the RIG-I signaling pathway, but growing evidence indicates that LGP2 is one cofactor of melanoma differentiation-associated protein 5 (MDA5) in MDA5-mediated IFN signaling activation. Our previous work showed that MDA5 was the major PRR to sense hepatitis C virus (HCV) infection in hepatocytes, but the role of LGP2 in HCV infection-induced IFN signaling has not been elucidated. In this study, we reported that LGP2 was a positive regulator of HCV infection-induced IFN signaling. Knockout of LGP2 in hepatocytes significantly diminished IFN production in response to HCV infection, but not to HCV 3'untranslated region RNA transfection. Mechanistic studies showed that LGP2 exerted its function at a step upstream of MDA5 in the IFN signaling. HCV infection promoted the molecular interaction between LGP2 and MDA5, which, in turn, enhanced MDA5/HCV RNA association. Finally, we demonstrated that the ATPase activity of LGP2 was critical for assisting MDA5/HCV RNA interaction and activating IFN signaling during HCV infection. Conclusion: Our work demonstrated that LGP2 plays an essential role in activating IFN signaling against HCV infection by promoting MDA5 recognition of HCV pathogen-associated molecular patterns.
A s the first line of host defense, the innate immune system deploys several types of pattern recognition receptors (PRRs) to detect and respond to the presence of intruding pathogens. PRRs recognize conserved molecular structures, known as pathogen-associated molecular patterns (PAMPs), that are essential for the life cycle of the pathogen, leading to activation of innate immune response.
(1) One group of PRRs, the retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), are cytosolic sensors that detect virus replication intermediates such as double-stranded RNA (dsRNA) or RNAs with triphosphorylated 5' termini. (2) (3) (4) RLRs comprise three members, RIG-I, melanoma differentiation-associated protein 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2), which all contain DExD/H box Abbreviations: ATP, adenosine triphosphate; CARD, caspase activation and recruitment domain; Co-IP, co-immunoprecipitation; dsRNA, doublestranded RNA; EDTA, ethylenediaminetetraacetic acid; eGFP, enhanced green fluorescent protein; EMCV, encephalomyocarditis virus; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; gDNA, genomic DNA; HA, hemagglutinin; HCV, hepatitis C virus; HCVcc, HCV-derived from cell culture; IFN, interferon; IgG, immunoglobulin G; IL, interleukin; ISG, interferon-stimulated gene; LGP2, laboratory of genetics and physiology 2; L-poly(I:C), long-poly(I:C); MAVS, mitochondrial antiviral signaling protein; MDA5, melanoma differentiation-associated protein 5; MOI, multiplicity of infection; MxA, myxovirus resistance protein A; NP-40, Nonidet P-40; NS, nonstructural; PAMPs, pathogen-associated molecular patterns; PBS, phosphate-buffered saline; poly(I:C), polyinosinic-polycytidylic acid; PRR, pattern recognition receptor; RIG-I, retinoic acid-inducible gene I; RIP, RNA immunoprecipitation; RLRs, RIG-I-like receptors; SeV, Sendai virus; sgRNA, single-guide RNA; UTR, untranslated region; WT, wild type.
RNA helicase domains. RIG-I and MDA5 recognize distinct subsets of PAMP. Whereas MDA5 detects long-duplex RNAs, RIG-I detects the 5'triphosphate group (5'ppp) and blunt end of short dsRNAs (<300 base pairs). (2) (3) (4) (5) The RNA ligands bind to the Cterminal of RIG-I or MDA5, inducing a conformational change of these proteins and exposing their Nterminal caspase activation and recruitment domains (CARD) to interact with the CARD domain of another protein, the mitochondrial antiviral signaling protein (MAVS), to initiate a cascade that eventually activates the transcription of type I and III interferons (IFNs), the primary antiviral cytokine and expression of diverse antiviral effector genes. (4, 6, 7) LGP2 presents at a low level in steady cells, but can be significantly induced in response to virus infection or polyinosinic-polycytidylic acid (poly(I:C)) treatment.
LGP2 shares a high homology amino acid sequence with RIG-I and MDA5 in their DExD/H box RNA helicase domains, (8) but lacks the Nterminal CARD domain. This deficiency makes LGP2 fail to autonomously transduce signaling, but potentially co-cooperate with other PRRs to regulate IFN signaling. (9) However, the exact roles of LGP2 in regulating IFN signaling still remain controversial.
LGP2 was originally regarded as a feedback inhibitor of antiviral responses because its overexpression effectively inhibits RIG-I-mediated IFN signaling. (9) (10) (11) (12) (13) However, recent growing evidence revealed a positive regulatory role of LGP2 in RLR signaling, particularly in MDA5-mediated IFN signaling. (10, (14) (15) (16) (17) Mice with Lgp2 locus disruption were more susceptible to various viral infections and had defects in antiviral IFN production. (14) Biochemical analysis of the PAMP of encephalomyocarditis virus (EMCV), a picornavirus sensed by MDA5, but not RIG-I, showed that the L region of the viral antisense RNA forms a complex with LGP2 to activate MDA5-mediated IFN signaling. (17) Previous studies showed that the inhibitory function of LGP2 was independent of its ATPase activity. (9, 12) However, an LGP2 mutant with an inactive ATPase failed to facilitate IFN response against MDA5-sensed viruses. (12, 14, 16) Furthermore, the paramyxovirus V protein functions as an IFN antagonist protein for its ability to disrupt adenosine triphosphate (ATP) hydrolysis activity of LGP2 by directly binding to LGP2 helicase domain. (18) These studies indicated the ATP hydrolysis is essential for LGP2's positive role in regulating IFN signaling.
Hepatitis C virus (HCV) infects approximately 170 million people worldwide, 80% of which develop into persistent infection. HCV has a 9.6-kilobase singlestranded RNA genome encoding a 3,000-amino-acid polyprotein containing structural proteins (core, E1, and E2) and nonstructural proteins (p7, nonstructural [NS] 2, NS3, NS4A, NS4B, NS5A, and NS5B). Untranslated regions (UTRs) at the 5' and 3' ends are highly conserved and play important roles in HCV genome replication and protein translation. It has been extensively studied how innate immunity senses viral PAMP during HCV infection. (4) Previous studies suggested that RIG-I is the cytosolic sensor of HCV in hepatocytes, because in vitro synthesized HCV 3'UTR RNA can be sensed by RIG-I to trigger IFN response after it is transfected into Huh7 cells. (19) (20) (21) We recently developed a system to probe into hepatic RLR for HCV in the context of virus infection. Interestingly, we found that although RIG-I may participate in early sensing of HCV infection, it is MDA5 that plays a predominant role in recognizing HCV PAMPs during HCV infection. (22) A recent study showed that MDA5 may recognize HCV dsRNA, the viral replicative intermediate to activate IFN signaling. (23) Despite these studies, the role of LGP2 in innate immune response against HCV infection has not yet been 
Materials and Methods

CELL CULTURE AND VIRUS PREPARATION
HEK293T cells and hepatic cells (Huh7, Huh7.5.1, and Huh7-MAVSR) were maintained in complete Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine serum, 10 mM of HEPES, 2 mM of L-glutamine, 100 U of penicillin/mL, and 100 mg of streptomycin/mL. All cells were cultured in humidified air containing 5% CO 2 at 37 8C. HCV-derived from cell culture (HCVcc) preparation and HCV 3'UTR RNA preparation were as described. (24) 
REAGENTS AND ANTIBODIES
Antibodies against hemagglutinin (HA), Flag, and b-actin were obtained from Abmart (Shanghai, China). HCV NS3 monoclonal antibody was generated by our laboratory. Long-poly(I:C) was purchased from Invivogen (San Diego, CA). The polyclonal rabbit antibody recognizing MDA5, RIG-I, and LGP2 were obtained from Cell Signaling Technology, Inc. (Danvers, MA). Goat/antimouse horseradish peroxidase antibody, normal mouse immunoglobulin G (IgG), and Protein A/G PLUS-Agarose were obtained from Santa Cruz Biotechnology (Heidelberg, Germany). Glycogen was purchased from Thermo Fisher Scientific (Waltham, MA).
PLASMID CONSTRUCTION
LGP2 complementary DNA was amplified from IFNa-treated Huh7 cells using the following primers: forward, 5
0 -GCAGAATGGAGCTTCGGTCCTA C-3 0 , and reverse, 5 0 -AGGTGGTCAGTCCAGG GAGAGG-3 0 . Flag-or HA-tagged LGP2 was cloned into lentiviral vector pLVX-IRES-zsGreen (Clontech Laboratories, Mountain View, CA). LGP2 mutations were generated by PCR and cloned into the EcoRI and XhoI sites of pLVX-HA-LGP2-IRES-zsGreen. All constructs were verified by sequencing analysis.
RNA ISOLATION, RT-qPCR
Protocols and sequences of primers for quantifying HCV RNA, human IFN-b, interleukin (IL)-28, IL-29, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were described. (24) Interferon-stimulated gene (ISG) 56 was quantified using the following primers: forward, 5 0 -TTCGGAGAAAGGCATTAGA, and reverse, 5 0 -TCCAGGGCTTCATTCATAT. Myxovirus resistance protein A (MxA) was quantified using the following primers: forward, 5 0 -ACAGGA CCATCGGAATCTTG, and reverse, 5 0 -CCCTTC TTCAGGTGGAACAC. HCV RNA was normalized to the cellular GAPDH levels and presented as 2 -DCt .
IMMUNOPRECIPITATION AND WESTERN BLOTTING
Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and lysed in ice-cold lysis buffer (20 mM of Tris/HCl [pH 7.4], 0.5% Nonidet P-40 [NP-40], 150 mM of NaCl, 1 mM of ethylenediaminetetraacetic acid [EDTA] , and protease inhibitor cocktail; Roche, Mannheim, Germany) for 20 minutes. Lysates were cleared by centrifugation at 10,000g at 4 8C for 10 minutes. Nonspecifically bound proteins were removed by adding 1 mg of normal mouse IgG, together with 20 mL of Protein A/G PLUS-Agarose at 4 8C for 40 minutes, followed by centrifugation at 1,000g for 5 minutes. Supernatants were incubated with 1 lg of specific antibodies at 4 8C overnight, then added with 20 mL of Protein A/G PLUS-Agarose for additional 2 hours. Beads were washed five times with ice-cold lysis buffer and resuspended in 40 mL of 2 3 loading buffer. Samples were analyzed by separation in sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting as described. (24) 
IMMUNOPRECIPITATION OF RLR-ASSOCIATED HCV RNA
Cells were washed twice with ice-cold PBS and lysed for 20 minutes in ice-cold lysis buffer (20 mM of Tris/HCl [pH 7.5], 0.5% NP-40, 150 mM of NaCl, 1 mM of EDTA, and protease inhibitor cocktail; Roche), supplemented with 2.5 U/mL of RNasin (Life technologies, Austin, TX) for coimmunoprecipitation (Co-IP) of RNA. One half of the immunocomplex beads were dissolved in 2 3 loading buffer for western blotting, and the other half were incubated with proteinase K (TAKARA, Dalian, China) at 42 8C for 2 hours. RNA was isolated as described. (24) 
GENERATION OF Huh7-MAVSR CELLS STABLY EXPRESSING LGP2
Lentiviruses expressing wild-type (WT) or mutant LGP2 were generated by cotransfecting pLVX-LGP2-IRES-zsGreen with the packaging vector, psPAX2, and envelope vector pMD2.G into HEK293T cells using Lipofectamine 2000 (Invitrogen). Culture supernatants containing lentiviruses were harvested at 48 hours posttransfection, passed through a 0.45-lm-pore-size filter, and used to infect WT or LGP2 knockout Huh7-MAVSR cells.
GENERATION OF Huh7-MAVSRsgLGP2 CELLS BY lenti-CRISPR-Cas9
HEK293T cells were seeded into six-well plates at a density of 7 
STATISTICAL ANALYSES
Statistical analyses were performed using unpaired, twotailed Student t test or one-way ANOVA as appropriate.
Results
LGP2 WAS REQUIRED FOR HCV INFECTION-INDUCED IFN RESPONSES
HCV-encoded NS3/4 serine protease can subvert host innate immune responses by cleaving MAVS, a critical adaptor protein in IFN signaling. To study how innate immunity senses HCV infection in hepatocytes, we previously established Huh7-MAVSR cells, in which the NS3/4A cleavage site in MAVS (amino acid residue position 508) was mutated from cysteine to arginine (C508R). (22) HCV infection induced robust IFN response in Huh7-MAVSR cells, allowing for investigation of IFN signaling pathway in the context of HCV infection. (22) We sought to utilize this system to study the role of LGP2 in activating IFN signaling during HCV infection.
First, we generated LGP2 knockout Huh7-MAVSR cells using the CRISPR-Cas9 technology. (25) Three LGP2 knockout cell lines were generated by using three different sgRNAs targeting exon 7 or 8 of LGP2, respectively (Supporting Fig. S1A ). gDNA sequencing results showed that insertion or deletion mutations were present around the target sites in all eight randomly picked LGP2 gDNA subcloned from each of the three knockout cell lines (Supporting Fig. S1B ). Because of low endogenous basal LGP2 protein levels in the Huh7-MAVSR cells and the poor sensitivity of the anti-LGP2 antibody, we were unable to verify the LGP2 knockout phenotype by western blotting even if the knockout cells were treated with IFN-a (data not shown).
Next, the three LGP2 knockout Huh7-MAVSR cells, together with a control cell expressing sgRNA targeting irrelevant enhanced green fluorescent protein (eGFP), were infected with HCVcc (Japanese fulminant hepatitis type 1 strain) at a multiplicity of infection (MOI) of 4. Type I and III IFNs as well as HCV-RNA levels were determined at the indicated time points postinfection by RT-qPCR. Consistent with our previous report, (22) HCV infection induced robust IFN responses in the control cell line (sgeGFP; Fig. 1A-C) . However, IFN-b, IL-28, and IL-29 production were severely impaired in all the LGP2 knockout cells. HCV-RNA levels were comparable among all groups on days 1 and 2 postinfection, suggesting that the lack of IFN responses in the LGP2 knockout cells was not attributed to inadequate HCV genome replication (Fig. 1D) . No significant cytopathic effect was observed in either cell lines up to 96 hours postinfection (data not shown). These results suggested that LGP2 was critical for activating IFN signaling in response to HCV infection.
ECTOPICALLY EXPRESSED LGP2 IN LGP2 KNOCKOUT CELLS RESCUED THE DEFECT IN IFN SIGNALING INDUCED BY HCV INFECTION
To rule out a possibility that the IFN-b production deficiency in the HCV-infected LGP2 knockout cells might be caused by the off-target effect of LGP2 sgRNAs, we reconstituted LGP2 expression in LGP2 knockout cells. sgLGP2-2# and sgLGP2-3# knockout Huh7-MAVSR cells were transduced with lentiviruses expressing HA-tagged LGP2 with modified sgRNAtargeting sequences resistance to the corresponding sgRNAs. Restoration of LGP2 expression in LGP2 knockout cells was verified by western blotting (Fig. 2A) . The reconstituted LGP2 knockout cells were then infected with HCVcc at an MOI of 4, and the IFN-b, two ISGs (ISG56 and MxA), and HCV-RNA levels were determined by RT-qPCR. Reconstitution of LGP2 expression not only rescued IFN-b and ISGs production in HCV-infected cells, but also significantly accelerated the kinetics given that the IFN-b, ISG56, and MxA induction became detected as early as day 1 postinfection and reached the peak at day 2 postinfection (Fig. 2B-D) . IFN-b levels in reconstituted cells dropped significantly at day 3 postinfection, correlating with a rapid decrease of HCV-RNA levels (Fig. 2E) , likely attributed to the antiviral action of ISGs induced during the first 2 days. These results suggested that LGP2 indeed played a positive role in HCV infection-induced IFN response. Enhanced IFN production in LGP2 reconstituted cells likely resulted from higher levels of LGP2 expression than in WT Huh7-MAVSR cells.
LGP2 WAS DISPENSABLE FOR ACTIVATING IFN SIGNALING IN RESPONSE TO HCV 3 0 UTR RNA, poly(I:C), OR SENDAI VIRUS To probe the specificity of LGP's role in IFN signaling, we examined whether LGP2 knockout had any effects on the IFN response triggered by synthetic dsRNA poly(I:C) or HCV 3 0 UTR RNA. Highmolecular-weight long-poly(I:C) (referred to as L-poly(I:C)) is a ligand for MDA5-mediated IFN signaling. (2, 22) The 3 0 UTR region of HCV genomic RNA, essential for viral genome replication, was recognized by RIG-I to activate IFN signaling. (19) (20) (21) (22) L-poly(I:C) and HCV 3 0 UTR RNA were transfected into the three LGP2 knockout and sgeGFP control Huh7-MAVSR cells, and IFN-b level was determined at 6, 12, and 16 hours posttransfection.
LGP2 knockout had no effect on IFN response induced 
FIG. 4.
LGP2 acted at a step upstream of MDA5 in IFN signaling induced by HCV infection. Plasmids expressing HA-LGP2, HA-MDA5, and control empty vector were transfected into LGP2 knockout (sgLGP2-3#), MDA5 knockout (sgMDA5-2#), (22) and control Huh7-MAVSR cells that had been infected with HCVcc (MOI 5 4) for 1 day. Cells were collected at the indicated time points for an RT-qPCR assay to analyze IFN-b (A,B) and HCV RNA (C,D). IFN-b is presented as mRNA fold induction relative to the noninfection control. Data are representative of three independent experiments with similar results. Error bars represent standard deviations of duplicates. *P < 0.05.
FIG. 3.
LGP2 knockout had no effect on IFN signaling induced by HCV 3'UTR RNA, poly(I:C), or SeV.
LGP2 knockout or con- by either L-poly(I:C) or HCV 3 0 UTR RNA (Fig. 3A,B) .
Next, we examined how LGP2 knockout affected IFN signaling induced by Sendai virus (SeV) infection, which is known to be mediated by RIG-I recognition. (26, 27) The three LGP2 knockout and sgeGFP control Huh7-MAVSR cells were infected with SeV, and IFN-b levels were determined at 6, 12, and 16 hours postinfection. IFN signaling activation was not affected by the LGP2 knockout (Fig. 3C) . Altogether, these results suggested that LGP2 was not required for the IFN signaling induced by L-poly(I:C), HCV 3 0 UTR RNA, or SeV, and the critical role of LGP2 in HCV infection-induced IFN response seemed to be related to some specific aspects in innate sensing of PAMP during HCV infection.
LGP2
PARTICIPATED IN HCV INFECTION-INDUCED IFN SIGNALING AT A STEP UPSTREAM OF MDA5
Our previous work identified that MDA5, rather than RIG-I, was the major PRR to sense HCV infection in hepatocytes. (22) Therefore, we next investigated the role of LGP2 in MDA5-mediated IFN signaling during HCV infection. Plasmids expressing MDA5 or LGP2 were transfected into LGP2 knockout Huh7-MAVSR, MDA5 knockout Huh7-MAVSR, (22) or control Huh7-MAVSR (sgeGFP) cells that had been infected with HCVcc at an MOI of 4 for 1 day. IFN-b and HCV-RNA levels at 48 and 72 hours postinfection were determined by RT-qPCR. Western blotting assay detected comparable levels of ectopically expressed HA-LGP2 and HA-MDA5 in these cells (Supporting Fig. S2 ). Overexpression of either MDA5 or LGP2 enhanced IFN-b production in control cells (sgeGFP) and LGP2 knockout cells (Fig. 4A,B) . However, only MDA5 overexpression rescued IFN signaling in MDA5 knockout cells, whereas LGP2 overexpression had little effect on IFN signaling in MDA5 knockout cells. HCV-RNA levels were negatively correlated with IFN-b levels (Fig.  4C,D) . These results demonstrated that MDA5 can rescue the phenotype of LGP2 knockout, but not vice versa, suggesting that both proteins likely acted in the same IFN signaling pathway, and that LGP2 may exert its positive regulatory role in HCV infectioninduced IFN signaling at a step upstream of MDA5.
HCV INFECTION PROMOTED THE INTERACTION BETWEEN LGP2 AND MDA5
Next, we examined the molecular interaction of LGP2 and RLRs in the context of HCV infection. Because endogenous LGP2 protein levels were not readily detected (data not shown), we used Huh7-MAVSR cells stably expressing HA-tagged LGP2 for this purpose.
LGP2 proteins in HCVcc-infected Huh7-MAVSR-HA-LGP2 cells were pulled down by an anti-HA antibody, and interacting PRRs were analyzed by western blotting. MDA5, but not RIG-I, specifically interacted with LGP2 following HCV infection (Fig. 5A) .
To confirm the molecular interactions between
LGP2 and MDA5, we performed additional Co-IP assay in Huh7 cells. Plasmids expressing HA-tagged
HEI AND ZHONG MDA5 and Flag-tagged LGP2 were transfected into Huh7 cells, and molecular interaction between the two proteins in the presence or absence of HCV infection was examined by the Co-IP assay. There was a low level of LGP2-MDA5 interaction in the uninfected cells, but this interaction increased significantly upon HCV infection (Fig. 5B) . Altogether, these results suggested that HCV infection can promote the molecular interaction between LGP2 and MDA5.
ENHANCED MDA5 INTERACTION WITH HCV RNA
A previous biochemical study showed that LGP2 can increase the initial rate of MDA5-dsRNA interaction and regulate MDA5 filament assembly. (28) To determine whether LGP2 can promote MDA5 and HCV-RNA interaction in the context of HCV infection, we conducted an RNA immunoprecipitation (RIP) experiment. Huh7 cells expressing HA-MDA5 with or without Flag-LGP2 were infected with HCVcc, and MDA5-associated complexes were purified by immunoprecipitation using anti-HA. HCV RNA was extracted from these immunocomplexes and analyzed by RT-qPCR. Western blotting showed a comparable amount of immunoprecipitated MDA5 in the presence or absence of LGP2, and LGP2 was coimmunoprecipitated by anti-HA (Fig. 6A) . Importantly, input intracellular HCV-RNA levels were comparable among all three groups (data not shown).
LGP2 significantly increased HCV-RNA levels in MDA5-associated complexes (Fig. 6B) , suggesting that LGP2 can promote MDA5 recognition of HCV RNA.
It has been shown that LGP2 can directly bind the HCV genome in vitro. (11) To examine whether LGP2 can bind HCV RNA during HCV infection, we performed an RIP experiment. Huh7 cells expressing Flag-LGP2 or control Flag-eGFP were infected with HCVcc, and LGP2-associated complexes were purified by immunoprecipitation using anti-Flag. HCV RNA was extracted from these immunocomplexes and analyzed by RT-qPCR. Western blotting showed that although both LGP2 and eGFP were efficiently immunoprecipitated (Fig. 6C) , significantly more HCV RNA was detected in the LGP2-associated complex (Fig. 6D) , suggesting that LGP2 can bind HCV RNA.
ATPase ACTIVITY OF LGP2 WAS REQUIRED FOR LGP2-MEDIATED IFN SIGNALING INDUCED BY HCV INFECTION
Previous studies demonstrated that a point mutation from lysine to alanine at amino acid residue 30 (K30A) in the Walker ATP-binding motif of LGP2 (Supporting Fig. S3A ) disrupted LGP2's basal and dsRNAstimulated ATPase activity. (16) Mice with the LGP2-K30A mutation failed to produce an IFN response to RNA virus infection and were highly susceptible to EMCV infection. (14) To determine whether LGP2 ATPase activity was also essential for HCV infectioninduced IFN signaling, we generated rescue cells stably expressing HA-tagged LGP2-K30A in LGP2 knockout Huh7-MAVSR cells (Supporting Fig. S3B ). The LGP2 knockout cells that had been reconstituted with WT or K30A mutant LGP2 were infected with HCVcc at an MOI of 4, and IFN-b and HCV RNA levels were determined by RT-qPCR. Although expression of WT LGP2 efficiently restored IFN-b production in response to HCV infection, expression of K30A mutant LGP2 failed to restore IFN-b production in LGP2 knockout cells, suggesting that ATPase activity was crucial for LGP2-mediated IFN signaling activation in response to HCV infection (Fig. 7A,B) .
Next, we examined whether the lack of ATPase activity in LGP2 affected its interaction with MDA5. Huh7 cells expressing HA-tagged MDA5 and Flag-tagged WT or K30A mutant LGP2 were infected with HCVcc, and MDA5-LGP2 interaction was examined by the Co-IP assay. HCV infection enhanced interaction between MDA5 and WT LGP2 (Fig. 7C) . However, although the K30A mutation did not affect basal MDA5-LGP2 interaction, it abolished the enhanced MDA5-LGP2 interaction induced by HCV infection. These results suggested that intact ATPase activity was required for HCV infectioninduced LGP2 and MDA5 interaction.
Finally, we performed an RIP assay to examine whether ATPase activity of LGP2 contributed to its enhancement of the MDA5-HCV RNA association. Huh7 cells expressing HA-MDA5 with WT or K30A mutant Flag-LGP2 were infected with HCVcc, and MDA5-associated complexes were purified by immunoprecipitation using anti-HA. HCV RNA associated with these immunocomplexes was analyzed by RTqPCR. A lesser amount of K30A mutant LGP2 was present in the MDA5-associated complex (Fig. 7D) , consistent with the observation (Fig. 7C ) that K30A mutation abolished HCV infection-induced MDA5-LGP2 interaction. Importantly, K30A mutant LGP2 failed to increase the abundance of HCV RNA in the MDA5-associated complex (Fig. 7E) . Altogether, these results suggested that LGP2 may utilize ATPase activity to facilitate the MDA5-HCV RNA association.
Discussion
The role of LGP2 in innate immune recognition of HCV infection in hepatocytes has not yet been explored. In this study, we provided several lines of evidence to demonstrate that LGP2 is an important positive regulator in IFN signaling in response to HCV infection. First, LGP2 knockout abolished the IFN production triggered by HCV infection (Figs. 1 and  2) . Second, ectopic expression of MDA5 could rescue the defect of the HCV infection-induced IFN production in LGP2 knockout cells, whereas ectopic expression of LGP2 could not rescue the defect of HCV infection-induced IFN production in MDA5 knockout cells, suggesting that LGP2 likely exerts its positive regulatory function at a step upstream of MDA5 (Fig.  4) . Biochemical analyses indicated that HCV infection promoted the LGP2-MDA5 interaction, and LGP2 enhanced binding of HCV RNA to MDA5 (Figs. 5  and 6 ). Finally, we showed that the contributions of LGP2 to HCV infection-induced IFN signaling were dependent upon on its intact ATPase activity (Fig. 7) . Taken together, these results demonstrated that LGP2 is a crucial positive regulator in innate immune response during HCV infection. Although these results were mainly obtained from a hepatoma cell line that was genetically modified in MAVS to become resistant to NS3/4A cleavage, it is unlikely that this modification in the downstream adaptor protein of the IFN signaling pathway would change the upstream RLR sensors that recognize HCV PAMP in the first place. Furthermore, our conclusion is consistent with previous findings that LGP2 assists IFN production in response to MDA5-sensed virus infection such as EMCV, (10, 14, 16, 17) and innate immune recognition of HCV infection in hepatocyes was mainly mediated by MDA5. (22, 23, 29) We found that LGP2 knockout had no effect on HCV 3 0 UTR RNA transfection-induced IFN signaling (Fig. 3) . HCV 3 0 UTR RNA, upon delivery into a cell by transfection, is a potent stimulator of RIG-Imediated IFN signaling (19) (20) (21) (22) ; however, our recent work suggested that the RIG-I recognition of HCV 3 0 UTR RNA may not be as critical as initially thought for activating IFN signaling in the context of HCV infection, because the RIG-I knockout had little effect on HCV infection-induced IFN signaling. (22) The differential LGP2 requirement for HCV infectioninduced and HCV 3 0 UTR RNA transfection-induced IFN signaling reinforced the notion that the involving PRRs could be totally different depending upon how PAMPs are delivered to the cells. After transfection into cells, HCV 3 0 UTR RNA is sensed by RIG-I, a process that does not require the involvement of LGP2. In fact, overexpression of LGP2 inhibited HCV 3 0 UTR RNA-induced IFN signaling (data not shown), consistent with the fact that LGP2 is a negative feedback regulator for RIG-I-mediated IFN response. (9) (10) (11) 30) In the context of HCV infection, however, the PAMP sequence residing within HCV 3 0 UTR RNA may be either functionally incorrectly folded or protected by viral components from the RIG-I access. Therefore, IFN signaling activation in the context HCV infection is not mainly mediated by RIG-I recognition of 3 0 UTR RNA. Our results suggested that LGP2 contributes to HCV infection-induced IFN signaling likely through facilitating MDA5 recognition of HCV RNA in an ATPase activity-dependent manner. This result is consistent with previous studies in that ATPase activity is required for the synergistic role of LGP2 and MDA5 in sensing other virus infection. (14, 16) A recent biochemical study reported that recognition of long dsRNA by MDA5 occurs by forming a long MDA5 filament wrapping the dsRNA, a step that is slow and rate limiting. LGP2 can increase the initial rate of MDA5-RNA interaction to form a larger number of shorter MDA5-LGP2 filaments that possess comparable, or even better, capacity to engage with MAVS and transduce signaling than the longer filaments containing only MDA5. (28) Based on our and other groups' data, we proposed a working model to explain the action of LGP2 in MDA5 recognition of HCV PAMP.
LGP2 first binds cytosolic HCV dsRNA in an ATPase activity-dependent manner, triggering a conformational change of LGP2 that leads to recruitment of MDA5 to form the MDA5 filaments containing LGP2 and HCV RNA. More experiments will be needed to test this hypothesis.
We also examined the effect of LGP2 knockout on the IFN signaling induced by L-poly(I:C), a ligand known to be recognized by MDA5. (22) Interestingly, we found that LGP2 knockout did not affect IFN-b production in response to L-poly(I:C) transfection (Fig. 3A) . This result suggested that the exact contribution of LGP2 to the MDA5 recognition of PAMPs may also depend on the nature of the PAMPs. It is plausible that the assembly of long MDA5 filaments along L-poly(I:C), a synthetic RNA duplex that lacks sophisticate secondary and tertiary RNA structures, may have a low energy barrier; therefore, this process can be carried out efficiently in the absence of LGP2 assistance. Therefore, LGP2 was not required for Lpoly(I:C)-induced MDA5-mediated IFN signaling activation.
